Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

750
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
750
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial aqueous suppressant therapy after glaucoma drainage device implantation: a systematic review.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Deep learning in glaucoma referral: Performance assessment using a real-world setting.

Acta ophthalmologica·2026
Same author

DESI-MSI applications for direct (spatial) biomolecular analysis of South African natural medicinal products.

Frontiers in plant science·2026
Same author

Prognostic factors for therapeutic keratoplasty in Acanthamoeba keratitis: a retrospective study.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Update on the structure-function relationship in glaucoma.

Survey of ophthalmology·2026
Same author

Glaucoma drainage devices as a novel treatment option in the management of recurrent iris cysts.

European journal of ophthalmology·2026

Related Experiment Video

Updated: Feb 23, 2026

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
09:26

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

20.7K

Clinical Metabolomics and Glaucoma.

João Barbosa-Breda1, Uwe Himmelreich, Bart Ghesquière

  • 1Laboratory of Ophthalmology, Department of Neurosciences, KU Leuven, Leuven, Belgium.

Ophthalmic Research
|September 1, 2017
PubMed
Summary

Metabolomics, the study of metabolites, shows promise for early glaucoma diagnosis and progression risk assessment. This research highlights potential biomarkers in blood plasma and ocular tissues for personalized glaucoma care.

Keywords:
BiomarkerClinicalGlaucomaMetabolomicsPathophysiology

More Related Videos

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
14:54

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

3.3K
In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

11.2K

Related Experiment Videos

Last Updated: Feb 23, 2026

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
09:26

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

20.7K
Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
14:54

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

3.3K
In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

11.2K

Area of Science:

  • Ophthalmology
  • Metabolomics
  • Biomarker Discovery

Background:

  • Glaucoma is a leading cause of irreversible blindness globally.
  • Current diagnostic and prognostic tools lack sufficient accuracy.
  • There is a critical need for reliable biomarkers for early detection and risk stratification.

Purpose of the Study:

  • To review the current findings of metabolomics research in glaucoma patients.
  • To explore the potential of metabolomics as a source of diagnostic and prognostic biomarkers for glaucoma.
  • To discuss the implications of metabolomics for personalized glaucoma management and therapeutic development.

Main Methods:

  • Systematic review of published studies on metabolomics in ophthalmology, focusing on human glaucoma research.
  • Analysis of studies utilizing mass spectrometry and nuclear magnetic resonance spectroscopy.
  • Comparison of metabolite profiles in glaucoma patients versus healthy controls.

Main Results:

  • Mass spectrometry identified significant differences in blood plasma, including pathways involving palmitoylcarnitine, sphingolipids, vitamin D, and steroid precursors.
  • Nuclear magnetic resonance spectroscopy revealed a high glutamine-glutamate/creatine ratio in the vitreous and lateral geniculate body.
  • Altered N-acetylaspartate/choline ratios were observed in specific brain regions associated with visual processing.

Conclusions:

  • Metabolomics offers a promising avenue for identifying novel biomarkers in glaucoma.
  • These findings support the potential for a personalized approach to glaucoma diagnosis and treatment.
  • Further research in metabolomics can deepen our understanding of glaucoma pathophysiology and uncover new therapeutic strategies.